Research programme: glucagon-like peptide-1 long-acting - PROLOR Biotech
Alternative Names: GLP-1-CTP; MOD-1001Latest Information Update: 08 Jun 2010
At a glance
- Originator Modigene
- Developer PROLOR Biotech
- Class Biological proteins; Glucagon-like peptides
- Mechanism of Action Glucagon-like peptide 1 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 08 Jun 2010 This programme is still in active development
- 18 Jul 2007 Preclinical trials in Type-2 diabetes mellitus in Israel (unspecified route)